United States v. Jaime Calderon

CourtCourt of Appeals for the Ninth Circuit
DecidedOctober 29, 2021
Docket20-10234
StatusUnpublished

This text of United States v. Jaime Calderon (United States v. Jaime Calderon) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Jaime Calderon, (9th Cir. 2021).

Opinion

NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS OCT 29 2021 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT

UNITED STATES OF AMERICA, No. 20-10234

Plaintiff-Appellee, D.C. Nos. 3:18-cr-08126-SPL-1 v. 3:18-cr-08126-SPL

JAIME CALDERON, AKA Jaime Arredonde, AKA Jaime Rene Calderon, MEMORANDUM*

Defendant-Appellant.

Appeal from the United States District Court for the District of Arizona Steven Paul Logan, District Judge, Presiding

Argued and Submitted October 19, 2021 San Francisco, California

Before: WATFORD and HURWITZ, Circuit Judges, and BAKER,** International Trade Judge.

Jaime Calderon challenges his convictions for multiple counts of aiding and

abetting possession of heroin with intent to distribute in violation of 21 U.S.C.

§ 841(a)(1), (b)(1)(C) and 18 U.S.C. § 2. We affirm.

* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. ** The Honorable M. Miller Baker, Judge for the United States Court of International Trade, sitting by designation. Page 2 of 5

1. Calderon contends that the district court committed reversible error by

admitting the expert testimony of Special Investigator Adrian Garcia without

making an express reliability finding. A district court “necessarily abuses its

discretion” when it makes no reliability finding pursuant to its gatekeeping

function under Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579

(1993). United States v. Valencia-Lopez, 971 F.3d 891, 898 (9th Cir. 2020).

Because the district court failed to make the required reliability finding, we must

determine whether this error was harmless.

To establish harmlessness, the government must show either that (1) the

record below establishes that the admitted testimony was relevant and reliable

under Daubert, or (2) it is more probable than not that the jury would have reached

the same verdict absent the evidence. United States v. Ruvalcaba-Garcia, 923

F.3d 1183, 1190 (9th Cir. 2019). The government has made both showings here.

First, the record establishes that Garcia’s testimony had “a reliable basis in

the knowledge and experience of the relevant discipline.” Id. (quoting Estate of

Barabin v. AstenJohnson, Inc., 740 F.3d 457, 463 (9th Cir. 2014) (en banc),

overruled on other grounds by United States v. Bacon, 979 F.3d 766 (9th Cir.

2020) (en banc)). Garcia’s testimony explaining the role and usage of cell phones

in prison was adequately supported by evidence in the record about his

qualifications, knowledge, and experience, which included approximately 30 Page 3 of 5

criminal investigations, hundreds of interviews related to the introduction of

contraband into prisons, and thousands of prison cell searches. See United States

v. Hankey, 203 F.3d 1160, 1169 (9th Cir. 2000). Second, it is more probable than

not that the jury would have reached the same verdict absent the evidence.

Garcia’s brief testimony did not concern the central issue at trial, identification of

Calderon’s voice on the recorded phone calls. See Valencia-Lopez, 971 F.3d at

902. Given the evidence presented on that issue, the jury would likely have

convicted Calderon even if Garcia had not testified. We thus conclude that the

district court’s error was harmless.1

2. Calderon next argues that the district court erred by prohibiting all

independent research concerning prospective and seated jurors. Because Calderon

again did not object below, despite having ample opportunity to do so, we review

only for plain error. Although we have concerns about the breadth of the district

court’s order, we find no plain error because Calderon has not shown that the

district court’s order affected his substantial rights. See United States v. Olano,

507 U.S. 725, 734–35 (1993). The parties submitted joint voir dire questions that

1 Calderon argues alternatively that he was not provided with the required notice regarding the scope of Garcia’s testimony. The testimony to which Calderon objects emerged on re-direct, following cross-examination. There was no objection to this testimony when it emerged below, so we review for plain error. See United States v. Blueford, 312 F.3d 962, 974 (9th Cir. 2002). We find no plain error here because Garcia’s testimony fell within the scope of the notice provided by the government. Page 4 of 5

the district court asked of prospective jurors, neither party was prohibited from

asking follow-up questions about any topic, and no challenges for cause were

denied. Nor does Calderon allege that any of the jurors who were ultimately seated

were biased or partial. Because any harm resulting from the district court’s order

is entirely speculative, Calderon has failed to demonstrate that his substantial rights

were affected.

3. Calderon is not entitled to relief based on alleged prosecutorial

misconduct. Calderon contends that the government committed misconduct in

relying on allegedly false testimony by Detective Roe. At trial, Roe testified about

a prior interaction he had with Calderon in 2013 or 2014. Calderon asserts that this

testimony was false because he was incarcerated during part of this period. To

prevail on this claim, Calderon must establish that: (1) the testimony was actually

false; (2) the government knew or should have known the testimony was false; and

(3) the testimony was material. United States v. Houston, 648 F.3d 806, 814 (9th

Cir. 2011). The testimony at issue fails the first prong of this test, as the date range

was offered as an approximation and spanned a period in which the interaction

between Calderon and Roe could have occurred. See United States v. Renzi, 769

F.3d 731, 752 (9th Cir. 2014).

4. Finally, the district court did not err in denying Calderon’s motion to

dismiss for lack of jurisdiction. We have previously held that the drug-trafficking Page 5 of 5

laws under which Calderon was convicted represent a valid exercise of Congress’s

authority under the Commerce Clause. United States v. Tisor, 96 F.3d 370, 374–

75 (9th Cir. 1996).

AFFIRMED.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Olano
507 U.S. 725 (Supreme Court, 1993)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
United States v. Houston
648 F.3d 806 (Ninth Circuit, 2011)
United States v. Lavern Hankey, AKA Poo, Opinion
203 F.3d 1160 (Ninth Circuit, 2000)
United States v. Roy Shelby Blueford
312 F.3d 962 (Ninth Circuit, 2002)
Estate of Henry Barabin v. Astenjohnson, Inc.
740 F.3d 457 (Ninth Circuit, 2014)
United States v. Richard Renzi
769 F.3d 731 (Ninth Circuit, 2014)
United States v. Mario Ruvalcaba-Garcia
923 F.3d 1183 (Ninth Circuit, 2019)
United States v. Enrique Valencia-Lopez
971 F.3d 891 (Ninth Circuit, 2020)
United States v. Patrick Bacon
979 F.3d 766 (Ninth Circuit, 2020)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Jaime Calderon, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-jaime-calderon-ca9-2021.